Among them, FOXD2-AS1 was positively correlated with 11 pathways, including ECM receptor interaction, MAPK signaling pathway, and some other cancer-related pathways, and negatively correlated with 9 pathways, mainly including REGULATION_OF_AUTOPHAGY and metabolism-related pathways. The gene discussed is FOXD2; the disease is cancer.